IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy-Reference-Cited by-同舟云学术

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Published:2001-07-01 Issue:1 Volume:108 Page:51-62
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Wigginton Jon M.,Gruys Eilene,Geiselhart Lisa,Subleski Jeffrey,Komschlies Kristin L.,Park Jong-Wook,Wiltrout Theresa A.,Nagashima Kunio,Back Timothy C.,Wiltrout Robert H.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference48 articles.

1. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

2. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet Dogs;Clinical Cancer Research;2024-07-09

2. Effect of anti-COVID-19 drugs on patients with cancer;European Journal of Medicinal Chemistry;2024-03

3. Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs;2024-02-14

4. Neutralization of p40 Homodimer and p40 Monomer Leads to Tumor Regression in Patient-Derived Xenograft Mice with Pancreatic Cancer;Cancers;2023-12-11

5. Regulation of human and mouse bystander T cell activation responses by PD-1;JCI Insight;2023-09-22